Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Price

Showing results (171-180 of 500) with videos related to

Pageof 50
Sort By:
Journal of Virology|March 6, 2015
Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1Geraldine M O'Connor, Julian P Vivian, Emma Gostick, et al.
Journal of Virology|June 20, 2015
Erratum for O'Connor et al., Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1Geraldine M O'Connor, Julian P Vivian, Emma Gostick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surfaceLinda Wooldridge, Sarah L Hutchinson, Ed M Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterizationKatayoun Rezvani, Jason M Brenchley, David A Price, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 7, 2008
Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramersPratip K Chattopadhyay, J Joseph Melenhorst, Kristin Ladell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2004
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDSAlmut Scherer, John Frater, Annette Oxenius, et al.
Blood|November 11, 2008
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrowJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Diabetes, Obesity & Metabolism|October 29, 2020
Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline dataAnne Peters, Nathan Cohen, Peter Calhoun, et al.
Journal of Molecular Biology|June 9, 2026
Biochemical basis for LRP1 interaction with Rift Valley fever virus glycoprotein and its role in viral entryFarheen Fatma, David A Price, Rachael E Rush, et al.
European Journal of Immunology|July 4, 2017
Curtailed T-cell activation curbs effector differentiation and generates CD8<sup>+</sup> T cells with a naturally-occurring memory stem cell phenotypeVeronica Zanon, Karolina Pilipow, Eloise Scamardella, et al.
Pageof 50

Showing results (171-180 of 500) with videos related to

Sort By:
Pageof 50
Journal of Virology|March 6, 2015
Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1Geraldine M O'Connor, Julian P Vivian, Emma Gostick, et al.
Journal of Virology|June 20, 2015
Erratum for O'Connor et al., Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1Geraldine M O'Connor, Julian P Vivian, Emma Gostick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surfaceLinda Wooldridge, Sarah L Hutchinson, Ed M Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterizationKatayoun Rezvani, Jason M Brenchley, David A Price, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 7, 2008
Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramersPratip K Chattopadhyay, J Joseph Melenhorst, Kristin Ladell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2004
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDSAlmut Scherer, John Frater, Annette Oxenius, et al.
Blood|November 11, 2008
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrowJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Diabetes, Obesity & Metabolism|October 29, 2020
Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline dataAnne Peters, Nathan Cohen, Peter Calhoun, et al.
Journal of Molecular Biology|June 9, 2026
Biochemical basis for LRP1 interaction with Rift Valley fever virus glycoprotein and its role in viral entryFarheen Fatma, David A Price, Rachael E Rush, et al.
European Journal of Immunology|July 4, 2017
Curtailed T-cell activation curbs effector differentiation and generates CD8<sup>+</sup> T cells with a naturally-occurring memory stem cell phenotypeVeronica Zanon, Karolina Pilipow, Eloise Scamardella, et al.
Pageof 50